Compounds > bisoprolol

bisoprolol and salmeterol xinafoate

bisoprolol has been researched along with salmeterol xinafoate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, JG1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Allen, TW1
Carrara, A; Conte, D; Occhipinti, V; Orlando, S; Segato, S1

Other Studies

6 other study(ies) available for bisoprolol and salmeterol xinafoate

ArticleYear
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    British journal of pharmacology, 2005, Volume: 144, Issue:3

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.
    Journal of medicinal chemistry, 2016, 06-23, Volume: 59, Issue:12

    Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship

2016
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
DOs encouraged to participate in pharmaceutical, clinical trials.
    The Journal of the American Osteopathic Association, 1994, Volume: 94, Issue:5

    Topics: Albuterol; Antihypertensive Agents; Bisoprolol; Bronchodilator Agents; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Drug Combinations; Hydrochlorothiazide; Interdepartmental Relations; Osteopathic Medicine; Salmeterol Xinafoate

1994
ERCP or NO ERCP: the case report of a frail patient.
    Internal and emergency medicine, 2018, Volume: 13, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzodiazepines; Bisoprolol; Bronchodilator Agents; Diuretics; Emergency Service, Hospital; Enalapril; Fluticasone; Frail Elderly; Furosemide; Humans; Male; Nordazepam; Pain Management; Pancreatitis; Pantoprazole; Salmeterol Xinafoate; Thyroxine; Tomography, X-Ray Computed; Ultrasonography

2018